Evidence map›Paper›PMID 28593351›Full record

ArticleDer Urologe. Ausg. A2017

[What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists].

M May, M W Vetterlein, F M Wagenlehner, S D Brookman-May, C Gilfrich, H-M Fritsche, P J Spachmann, M Burger, M Schostak, S Lebentrau and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The quality of antimicrobial prescribing in acute care hospitals: results derived from a national point prevalence survey, Germany, 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M MayUrologische Klinik, St. Elisabeth Klinikum, St.-Elisabeth-Str. 23, 94315, Straubing, Deutschland. matthias.may@klinikum-straubing.de.
M W VetterleinUrologische Universitätsklinik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
F M WagenlehnerUrologische Universitätsklinik, Justus-Liebig Universitätsklinikum, Rudolf-Buchheim-Str. 7, 35392, Gießen, Deutschland.
S D Brookman-MayKlinik für Urologie, LMU München, Marchioninistraße 15, 81377, München, Deutschland.
C GilfrichUrologische Klinik, St. Elisabeth Klinikum, St.-Elisabeth-Str. 23, 94315, Straubing, Deutschland.
H-M FritscheUrologische Universitätsklinik, Universität Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland.
P J SpachmannUrologische Universitätsklinik, Universität Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland.
M BurgerUrologische Universitätsklinik, Universität Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland.
M SchostakUrologische Universitätsklinik, Universitätsklinikum Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Deutschland.
S LebentrauUrologische Klinik, Ruppiner Kliniken, Fehrbelliner Str. 38, 16816, Neuruppin, Deutschland.
MR2-Studiengruppe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to increasing antibiotic resistances, relevant treatment problems are currently emerging in clinical practice. In March 2015, the German Federal Ministry of Health (BMG) published a 10-point plan designed to combat this development. Furthermore, the first German guideline on antibiotic stewardship (ABS) was implemented in 2013 and instructs physicians of different specialties about several treatment considerations. Evidence is scarce on how such concepts (10-point plan/BMG, ABS) are perceived among clinicians. MATERIALS AND

methodsWithin the MR2 study (Multiinstitutional Reconnaissance of practice with MultiResistant bacteria - a survey focusing on German hospitals), a questionnaire including 4 + 35 items was sent to 18 German hospitals between August and October 2015, surveying internists, gynecologists, general surgeons, and urologists. Using multivariate logistic regression models (MLRM), the impact of medical specialty and further criteria on the endpoints (1) awareness of the 10-point plan/BMG and (2) knowledge of ABS measures were assessed. Fulfillment of endpoints was predefined when average or full knowledge was reported (reference: poor to no knowledge).

resultsOverall response rate was 43% (456/1061) for fully evaluable questionnaires. Only 63.0 and 53.6% of urologists and nonurologists (internists, gynecologists, and general surgeons), respectively, attended training courses regarding multidrug-resistance or antibiotic prescribing in the 12 months prior to the study (P = 0.045). The endpoints average and full knowledge regarding 10-point plan/BMG and ABS measures were fulfilled in only 31.4 and 32.8%, respectively. In MLRM, clinicians with at least one previous training course (reference: no training course) were 2.5- and 3.8-fold more likely to meet respective endpoint criteria (all P < 0.001). Medical specialty (urologists vs. nonurologists) did not significantly impact the endpoints in both MLRM.

conclusionsThe 10-point plan/BMG and ABS programs should be implemented into clinical practice, but awareness and knowledge of both is insufficient. Thus, it stands to reason that the actual realization of such measures is inadequate and continuous training towards rational prescription of antibiotics is necessary, regardless of medical specialty.

Indexed as

Drug Resistance, Multiple, BacterialInterdisciplinary CommunicationIntersectoral CollaborationAntimicrobial StewardshipAttitude of Health PersonnelGermanyHumansNational Health ProgramsSurveys and QuestionnairesUrologyAntibiotic stewardshipFurther educationMedical specialtiesMultidrug resistanceSurveys and questionnaires

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.